IP Group has returned for a series B round raised by Ieso Digital Health, having initially acquired stakes in the business through its purchase of Touchstone.
Ieso Digital Health, a UK-based digital therapeutics platform, closed a £39m ($53m) series B round yesterday featuring commercialisation firm IP Group.
Morningside led the round, while Sony Innovation Fund, a corporate venturing vehicle for conglomerate Sony, Molten Ventures and Ananda Impact Ventures also participated.
Founded in 2000, Ieso Digital Health has developed artificial intelligence (AI)-equipped digital assessment tools and therapeutics to provide treatment for mental health afflictions such as anxiety and depression.
The company is also seeking regulatory approval for…
